Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
Scientists have taken a small but significant step toward testing the idea of reverse aging in humans. Researchers have treated the first participant in a clinical trial exploring whether older cells ...
A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be rejuvenated and potentially opening a new chapter in the science of aging.
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
A small cut that would close in days on a 30-year-old can linger for weeks on someone in their 70s. Surgical incisions heal slower. Diabetic ulcers stall. For decades, clinicians have treated this ...
An exploratory clinical study has found that semaglutide may favourably influence certain DNA-based biomarkers linked to ...
Anti-aging influencer Bryan Johnson joins 'The Sunday Briefing' to discuss the growing anti-aging movement, including a ...